272 related articles for article (PubMed ID: 21903474)
1. Update on antibacterial and antifungal drugs - can we master the resistance crisis?
Theuretzbacher U; Mouton JW
Curr Opin Pharmacol; 2011 Oct; 11(5):429-32. PubMed ID: 21903474
[No Abstract] [Full Text] [Related]
2. Current world literature. Antimicrobial agents: bacterial/fungal.
Curr Opin Infect Dis; 2003 Dec; 16(6):613-28. PubMed ID: 15043065
[No Abstract] [Full Text] [Related]
3. Antibacterial and antifungal drug discovery.
Persidis A
Nat Biotechnol; 1999 Nov; 17(11):1141-2. PubMed ID: 10545930
[No Abstract] [Full Text] [Related]
4. Repositioning or Redirection of Antidepressant Drugs in the Treatment of Bacterial and Fungal Infections.
da Rosa TF; Machado CS; Serafin MB; Bottega A; Foletto VS; Coelho SS; Hörner R
Am J Ther; 2020; 27(5):e528-e532. PubMed ID: 31082830
[No Abstract] [Full Text] [Related]
5. [Chemo-antibiotico-therapy today. I].
Cairella M; Marasa G
Clin Ter; 1974 Jun; 69(6):561-84. PubMed ID: 4845638
[No Abstract] [Full Text] [Related]
6. Antibiotic and antifungal resistance in antibiotic "free" environment?
Krcmery V; Kalavsky E
Neuro Endocrinol Lett; 2007 Nov; 28 Suppl 3():33-4. PubMed ID: 18030277
[No Abstract] [Full Text] [Related]
7. [Antimicrobial resistance].
Salzberger B; Welte T
Internist (Berl); 2015 Nov; 56(11):1231-2. PubMed ID: 26507817
[No Abstract] [Full Text] [Related]
8. [Non-polyenic antifungal macrolide antibiotics].
Shenin IuD
Antibiot Khimioter; 1991 Oct; 36(10):50-4. PubMed ID: 1805700
[No Abstract] [Full Text] [Related]
9. Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties.
Gupta AK; Plott T
Int J Dermatol; 2004 Jul; 43 Suppl 1():3-8. PubMed ID: 15271193
[No Abstract] [Full Text] [Related]
10. Therapy for fungal diseases: opportunities and priorities.
Denning DW; Hope WW
Trends Microbiol; 2010 May; 18(5):195-204. PubMed ID: 20207544
[TBL] [Abstract][Full Text] [Related]
11. [Prevention, diagnosis and therapy of infections in patients with malignant diseases].
Hiddemann W; Maschmeyer G; Runde V; Einsele H
Internist (Berl); 1996 Dec; 37(12):1212-24. PubMed ID: 9081922
[No Abstract] [Full Text] [Related]
12. Establishing a list of qualifying pathogens under the Food and Drug Administration Safety and Innovation Act. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2014 Jun; 79(108):32464-81. PubMed ID: 24908687
[TBL] [Abstract][Full Text] [Related]
13. Coping with antibiotic resistance: the impending crisis.
Gould IM
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S1-2. PubMed ID: 21129626
[TBL] [Abstract][Full Text] [Related]
14. Current world literature. Antimicrobial agents: bacterial/fungal.
Curr Opin Infect Dis; 2001 Dec; 14(6):769-73. PubMed ID: 11971278
[No Abstract] [Full Text] [Related]
15. [How do fungal infections "escape" treatment? Resistance and resistance mechanisms].
Morschhäuser J
Pharm Unserer Zeit; 2003; 32(2):124-8. PubMed ID: 12677965
[No Abstract] [Full Text] [Related]
16. [Antimicrobial prophylaxis and therapy in neutropenia].
Link H
Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial drug development: challenges, recent developments, and future considerations.
Nambiar S; Laessig K; Toerner J; Farley J; Cox E
Clin Pharmacol Ther; 2014 Aug; 96(2):147-9. PubMed ID: 25056394
[TBL] [Abstract][Full Text] [Related]
18. [Physiopathology and therapy in patients with respiratory tract infections].
Saito A
Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):433-6. PubMed ID: 8315342
[No Abstract] [Full Text] [Related]
19. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.
Sinkó J; Kullberg BJ; Edwards JE; Anaissie E
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i41-3. PubMed ID: 19372182
[No Abstract] [Full Text] [Related]
20. Symposium on antimicrobial agents.
Hermans PE
Mayo Clin Proc; 1983 Jan; 58(1):3-5. PubMed ID: 6823151
[No Abstract] [Full Text] [Related]
[Next] [New Search]
